Global Fund COVID-19 Situation Report – 27 October 2020 Global cases: : 43,341,451 confirmed. Global deaths: 1,157,509 confirmed. COVID-19 has infected 43.3 million people and killed 1.1 million since the outbreak emerged last December. “We are at a critical juncture in the pandemic” said WHO Director-General, as many countries are now seeing an exponential increase in […]
Unitaid welcomes US$40 million from Norway to fight COVID-19 22 December 2020 Geneva – Unitaid is pleased to welcome a contribution of NOK 350 million (US$40 million) from Norway towards its vital work on COVID-19 treatments and tests. As a founding member of Unitaid, Norway has been a longstanding supporter of its efforts to bring forward life-saving […]
COVAX now has agreements in place to access nearly two billion doses of several promising vaccine candidates, and laid the groundwork for further doses to be secured through contributions from donors These agreements mean that all COVAX’s 190 participating and eligible economies will be able to access doses to protect vulnerable groups in the first […]
Global Fund has awarded $1 billion to support countries’ COVID-19 responses, but funding for this purpose is now fully deployed GENEVA – The Global Fund has awarded nearly US$1 billion to 106 countries to support their responses to COVID-19, but has now fully deployed all its funding for this purpose. There are significant further needs for […]
Unitaid welcomes contribution from Canada 16 December 2020 Geneva – Unitaid welcomes contribution of C$15 million (US$11.7 million) from Canada to its ongoing work on COVID-19 therapeutics and diagnostics under the global Access to Covid-19 Tools (ACT) Accelerator. The funding, which forms part of a C$255 million overall package of support to the ACT-Accelerator, has been allocated […]
December 23rd, 2020 Unitaid welcomes contribution from Canada 16 December 2020 Geneva – Unitaid welcomes contribution of C$15 million (US$11.7 million) from Canada to its ongoing work on COVID-19 therapeutics and diagnostics under the global Access to Covid-19 Tools (ACT) Accelerator. The funding, which forms part of a C$255 million overall package of support to the ACT-Accelerator, […]
COVAX now has agreements in place to access nearly two billion doses of several promising vaccine candidates, and laid the groundwork for further doses to be secured through contributions from donors These agreements mean that all COVAX’s 190 participating and eligible economies will be able to access doses to protect vulnerable groups in the first […]
Global Fund has awarded $1 billion to support countries’ COVID-19 responses, but funding for this purpose is now fully deployed GENEVA – The Global Fund has awarded nearly US$1 billion to 106 countries to support their responses to COVID-19, but has now fully deployed all its funding for this purpose. There are significant further needs for […]
Unitaid welcomes US$40 million from Norway to fight COVID-19 22 December 2020 Geneva – Unitaid is pleased to welcome a contribution of NOK 350 million (US$40 million) from Norway towards its vital work on COVID-19 treatments and tests. As a founding member of Unitaid, Norway has been a longstanding supporter of its efforts to bring forward life-saving […]
Pacific Friends of Global Health is deeply saddened to hear of the passing of Sir Mekere Morauta KCMG. Sir Mekere will be remembered for his enormous contributions to the stability and reform of Papua New Guinea, serving as PNG’s 7th Prime Minister from 1999 to 2002. Professor Brendan Crabb AC, Chair of the Pacific Friends […]
December 20th, 2020 Pacific Friends of Global Health is deeply saddened to hear of the passing of Sir Mekere Morauta KCMG. Sir Mekere will be remembered for his enormous contributions to the stability and reform of Papua New Guinea, serving as PNG’s 7th Prime Minister from 1999 to 2002. Professor Brendan Crabb AC, Chair of […]
December 2nd, 2020 Geneva, 1 December 2020 New formulation is dispersible and strawberry-flavoured, enabling the youngest children living with HIV to be treated with the best available medication New price agreement with Viatris and Macleods will significantly lower cost for yearly paediatric HIV treatment from over $480 per child to under $120 per child[1] Innovative partnership has […]
December 1st, 2020 Innovation and investment needed to protect valuable HIV gains against COVID19 As the world continues to fight the COVID19 pandemic, we must remember that we haven’t finished the fight against the last major pandemic to hit humanity: HIV. As of 2019, there were 38 million people living with HIV across the globe. […]
